[New post] UOBKH: CSPC Pharmaceutical Group (1093 HK)

alanyeo posted: " 1H21: Adjusted Net Earnings Up 30.4% yoy; Making Progress In R&D And BDCSPC reported stronger-than-expected 1H21 results, with revenue up 9.8% yoy to Rmb13.82b and adjusted net profit growing 30.4% yoy to Rmb2.67b. Aside from the strong performance o" Respond to this post by replying above this line New post on Alpha Edge Investing UOBKH: CSPC Pharmaceutical Group (1093 HK) by alanyeo 1H21: Adjusted Net Earnings Up 30.4% yoy; Making Progress In R&D And BDCSPC reported stronger-than-expected 1H21 results, with revenue up 9.8% yoy to Rmb13.82b and adjusted net profit growing 30.4% yoy to Rmb2.67b. Aside from the strong performance on the commercial front, CSPC is also making significant progress in R&D and BD. Its extensive R&D […] Read more of this post alanyeo | August 27, 2021 at 3:15 pm | Categories: Equities - Research Reports by Brokers/ Banks | URL: https://wp.me/p7fA1-3lX Comment    See all comments    Like Unsubscribe to no longer receive posts from Alpha Edge Investing. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: http://alphaedgeinvesting.com/2021/08/27/uobkh-cspc-pharmaceutical-group-1093-hk/ Thanks for flying with WordPress.com